|
| 38054619 | Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS-CoV-2 infection and vaccination. | Transfusion | 2024 |
| 38018462 | A novel mitigation strategy for the prevention of transfusion-transmitted malaria. | Transfusion | 2024 |
| 36373203 | Occupations Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Vaccination, US Blood Donors, May 2021-December 2021. | Clin Infect Dis | 2023 |
| 37767285 | Molecular Screening of Blood Donors for <i>Babesia</i> in Tyrol, Austria. | Transfus Med Hemother | 2023 |
| 37250174 | Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras. | Open Forum Infect Dis | 2023 |
| 37262007 | Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022. | MMWR Morb Mortal Wkly Rep | 2023 |
| 36922181 | Reply to Hoad et al. Comment on White paper on pandemic preparedness in the blood supply. | Vox Sang | 2023 |
| 36606513 | Validity of donor-reported iron supplementation practices obtained at the time of donation. | Transfusion | 2023 |
| 36427057 | White paper on pandemic preparedness in the blood supply. | Vox Sang | 2023 |
| 36528466 | Eligibility Considerations for Female Whole Blood Donors: Hemoglobin Levels and Iron Status in a Nationally Representative Population. | Transfus Med Rev | 2023 |
| 34793330 | Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness. | JCI Insight | 2022 |
| 35441384 | The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan. | Transfusion | 2022 |
| 35834347 | Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma. | J Clin Invest | 2022 |
| 35726756 | Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction. | Transfusion | 2022 |
| 35750589 | Demographic, clinical, and biochemical predictors of pica in high-intensity blood donors. | Transfus Med | 2022 |
| 35748490 | Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components. | Transfusion | 2022 |
| 36751647 | A Longitudinal Study of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response in a Subset of United States Blood Donors. | Open Forum Infect Dis | 2022 |
| 35916553 | Iron status of blood donors. | Curr Opin Hematol | 2022 |
| 35321643 | Sex-specific genetic modifiers identified susceptibility of cold stored red blood cells to osmotic hemolysis. | BMC Genomics | 2022 |
| 32974931 | Iron status and self-reported fatigue in blood donors. | Transfusion | 2021 |
| 33491765 | Filariasis and transfusion-associated risk: a literature review. | Vox Sang | 2021 |
| 33913181 | Demographic, clinical, and biochemical predictors of pica in a large cohort of blood donors. | Transfusion | 2021 |
| 34014839 | Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage. | J Clin Invest | 2021 |
| 34373145 | Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines. | Transfus Med Rev | 2021 |
| 33119070 | Association of proton pump inhibitor and histamine H2-receptor antagonists with restless legs syndrome. | Sleep | 2021 |
| 31566724 | Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets. | Br J Haematol | 2020 |
| 32061102 | The evanescence and persistence of RBC alloantibodies in blood donors. | Transfusion | 2020 |
| 32073674 | Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors. | Transfusion | 2020 |
| 32931411 | Oral iron and blood donation: cui bono? | Blood Transfus | 2020 |
| 32243609 | The benefits of iron supplementation following blood donation vary with baseline iron status. | Am J Hematol | 2020 |
| 32382935 | Early and sustained improvement in fatigue-related quality of life following red blood cell transfusion in outpatients. | Qual Life Res | 2020 |
| 32163187 | Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors. | Transfusion | 2020 |
| 30408207 | Intradonor reproducibility and changes in hemolytic variables during red blood cell storage: results of recall phase of the REDS-III RBC-Omics study. | Transfusion | 2019 |
| 31503347 | Expanded feasibility of ferritin testing: stability of ferritin stored as whole blood and validation of plastic tubes. | Transfusion | 2019 |
| 31466604 | Iron Depletion in Adult and Teenage Blood Donors: Prevalence, Clinical Impact, and Options for Mitigation. | Hematol Oncol Clin North Am | 2019 |
| 31318071 | Iron status and risk factors for iron depletion in a racially/ethnically diverse blood donor population. | Transfusion | 2019 |
| 31218700 | Iron supplementation by blood donors: demographics, patterns of use, and motivation. | Transfusion | 2019 |
| 30882919 | Therapeutic impact of red blood cell transfusion on anemic outpatients: the RETRO study. | Transfusion | 2019 |
| 30633813 | Elevated risk for iron depletion in high-school age blood donors. | Transfusion | 2019 |
| 30427537 | Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). | Transfusion | 2019 |
| 30267427 | Blood, sweat, and tears: Red Blood Cell-Omics study objectives, design, and recruitment activities. | Transfusion | 2019 |
| 30474858 | Frequent blood donations alter susceptibility of red blood cells to storage- and stress-induced hemolysis. | Transfusion | 2019 |
| 28703859 | The operational implications of donor behaviors following enrollment in STRIDE (Strategies to Reduce Iron Deficiency in blood donors). | Transfusion | 2017 |
| 28164344 | Qualitative assessment of pica experienced by frequent blood donors. | Transfusion | 2017 |
| 28494509 | Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy. | Am J Hematol | 2017 |
| 26813849 | A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. | Transfusion | 2016 |
| 27237451 | Potential impact on blood availability and donor iron status of changes to donor hemoglobin cutoff and interdonation intervals. | Transfusion | 2016 |
| 27532622 | Evidence for Transmission of Zika Virus by Platelet Transfusion. | N Engl J Med | 2016 |
| 27232535 | Effect of iron supplementation on iron stores and total body iron after whole blood donation. | Transfusion | 2016 |
| 25469720 | The strategies to reduce iron deficiency in blood donors randomized trial: design, enrolment and early retention. | Vox Sang | 2015 |